[Experience with the use of vilozen in patients with bronchial asthma].
The results of the use of vilozen in the treatment of bronchial asthma patients are presented. The efficacy of the drug for asthma of different genesis is demonstrated. Vilozen stimulates functions of cellular immunity and produces a moderate inhibitory effect on phagocytosis function. The drug is contraindicated in the treatment of patients with bacterial infection and pronounced obstructive syndrome.
Ialkut
S I
SI
Kotova
S A
SA
D000276:Adjuvants, Immunologic / Q000008:administration & dosage / Q000627:therapeutic use*; D000281:Administration, Intranasal; D000917:Antibody Formation / Q000187:drug effects / Q000276:immunology; D001249:Asthma / Q000188:drug therapy* / Q000276:immunology; D004341:Drug Evaluation; D006801:Humans; D007111:Immunity, Cellular / Q000187:drug effects / Q000276:immunology; D012996:Solutions; D013949:Thymus Extracts / Q000008:administration & dosage / Q000627:therapeutic use*; D013997:Time Factors
D000276:Adjuvants, Immunologic; D012996:Solutions; D013949:Thymus Extracts; C059606:iilozen
Opyt primeneniia vilozena u bol'nykh bronkhial'noĭ astmoĭ.